MedTrace Logo

Serocorrelate of Protection Against GBS (PREPARE WP3)

NCT04732026 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-10-26

No results posted yet for this study

Summary

A multicentre, international case-control study to develop a biobank of sera from 150 cases of serotype III GBS disease and associated clinical information from seven countries (Malawi, Uganda, UK, the Netherlands, Italy and France), with 3:1 (450) serotype matched healthy controls.

Conditions

  • Group B Streptococcus Carrier in Childbirth
  • Group B Streptococcal Infection, Late-Onset
  • Group B Streptococcal Infection, Early-Onset
  • Group B Streptococcus Neonatal Sepsis
  • Group B Strep Infection

Sponsors & Collaborators

  • MU-JHU CARE

    collaborator OTHER

  • MRC/UVRI and LSHTM Uganda Research Unit

    collaborator OTHER

  • University of Liverpool

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Azienda Ospedaliero-Universitaria di Modena

    collaborator OTHER

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Kirsty Le Doare, Prof · St George's, University of London

  • Stephen Cose, Dr · London School of Hygiene and Tropical Medicine

Eligibility

Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2024-03-01
Completion
2024-04-01

Countries

  • France
  • Italy
  • Malawi
  • Netherlands
  • Uganda
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04732026 on ClinicalTrials.gov